Drug Shortage Report for NALOXONE HCL INJECTION - 1MG/ML USP
| Report ID | 181704 |
| Drug Identification Number | 02148714 |
| Brand name | NALOXONE HCL INJECTION - 1MG/ML USP |
| Common or Proper name | NALOXONE HCL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | NALOXONE HYDROCHLORIDE |
| Strength(s) | 1MG |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 2ML |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-01-18 |
| Estimated end date | 2023-03-17 |
| Actual end date | 2023-03-20 |
| Shortage status | Resolved |
| Updated date | 2023-03-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-03-21 | English | Compare |
| v4 | 2023-03-20 | French | Compare |
| v3 | 2023-03-20 | English | Compare |
| v2 | 2023-01-19 | French | Compare |
| v1 | 2023-01-19 | English | Compare |
Showing 1 to 5 of 5